IBJNews

Lilly settles Zyprexa case with S. Carolina for $45M

Back to TopCommentsE-mailPrintBookmark and Share

South Carolina Attorney General Henry McMaster said Friday that the state has reached a $45 million settlement with drug maker Eli Lilly and Co. over the company's marketing of an anti-psychotic drug.

McMaster's office said the agreement is the second largest settlement deal in state history.

McMaster sued the Indianapolis-based drug maker in 2007, arguing it had improperly marketed Zyprexa. The settlement recovers state funds used to treat illnesses allegedly caused by the drug.

Earlier this month, McMaster said he would return campaign contributions from two attorneys he hired to assist the state in its lawsuit.

Lilly officials did not immediately return a message Friday.

Lilly confirmed earlier this month that it had reached a tentative settlement with South Carolina, but did not disclose a dollar figure.

Zyprexa, which boasts $4.7 billion in annual sales, has cost Lilly lots of legal trouble, sparking thousands of patient lawsuits as well as investigations by federal and state governments.

In January, Lilly agreed to pay $1.42 billion to federal and state governments to resolve a lawsuit over Zyprexa marketing brought by the U.S. Justice Department. South Carolina did not join that settlement.

More than 30 states have sued Lilly over Zyprexa.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT